Targeting Mitochondria to Control Ageing and Senescence
Pharmaceutics · 20.01.2023 · 15 (2) · 352
DOI: 10.3390/pharmaceutics15020352 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.01.2023. Verfasst von Margherita Protasoni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission under 'Marie Skłodowska-Curie Actions', Individual Fellowship, European Research Council, Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia.
Abstract (Originalsprache)
Ageing is accompanied by a progressive impairment of cellular function and a systemic deterioration of tissues and organs, resulting in increased vulnerability to multiple diseases. Here, we review the interplay between two hallmarks of ageing, namely, mitochondrial dysfunction and cellular senescence. The targeting of specific mitochondrial features in senescent cells has the potential of delaying or even reverting the ageing process. A deeper and more comprehensive understanding of mitochondrial biology in senescent cells is necessary to effectively face this challenge. Here, we discuss the main alterations in mitochondrial functions and structure in both ageing and cellular senescence, highlighting the differences and similarities between the two processes. Moreover, we describe the treatments available to target these pathways and speculate on possible future directions of anti-ageing and anti-senescence therapies targeting mitochondria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
- Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Spain.
- Cambridge Institute of Science, Altos Labs, Granta Park, Cambridge CB21 6GP, UK.
ORCID-Profile: Manuel Serrano
Förderung
- European Commission under 'Marie Skłodowska-Curie Actions', Individual Fellowship
- European Research Council
- Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia
- the European Regional Development Fund (ERDF)
- European Commission under ‘Marie Skłodowska-Curie Actions’, Individual Fellowship
- Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia
Zitieren
APA
Protasoni, M., & Serrano, M. (2023). Targeting Mitochondria to Control Ageing and Senescence. Pharmaceutics, 15(2), 352. https://doi.org/10.3390/pharmaceutics15020352
Vancouver
Protasoni M, Serrano M. Targeting Mitochondria to Control Ageing and Senescence. Pharmaceutics. 2023;15(2):352. doi:10.3390/pharmaceutics15020352
BibTeX
@article{Protasoni2023,
author = {Protasoni, Margherita and Serrano, Manuel},
title = {Targeting Mitochondria to Control Ageing and Senescence},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {352},
doi = {10.3390/pharmaceutics15020352}
}
EUVIMED